OncoSec Medical Incorporated
ONCS
ONCS was delisted on the 23rd of June, 2023.
23 hedge funds and large institutions have $2.51M invested in OncoSec Medical Incorporated in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 3 closing their positions.
8% less funds holding
Funds holding: 25 → 23 (-2)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
35% less capital invested
Capital invested by funds: $3.86M → $2.51M (-$1.35M)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$9.41K |
| 2 |
VF
Virtu Financial
New York
|
+$8.16K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.11K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.32K |
| 5 |
TAM
Tocqueville Asset Management
New York
|
+$691 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$25.3K |
| 2 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
-$12K |
| 3 |
BlackRock
New York
|
-$9.75K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$9.59K |
| 5 |
Renaissance Technologies
New York
|
-$3.76K |
ONCS Hedge Fund Activity: Q3 2022 in Review
23 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q3 2022, worth a combined $2.51M — down 35% from $3.86M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ONCS and 1 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 5 added.
The largest buyer was Susquehanna International Group, adding an estimated $9.41K. The largest seller was Citadel Advisors, cutting an estimated $25.3K.
- 23 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q3 2022, down from 25 in Q2 2022.
- Funds reported $2.51M of OncoSec Medical Incorporated stock for Q3 2022, down 35% quarter-over-quarter.
- 1 fund opened new OncoSec Medical Incorporated positions in Q3 2022 and 3 closed out, a net change of -2 holders.
- The largest OncoSec Medical Incorporated buyer in Q3 2022 was Susquehanna International Group, an estimated $9.41K added.
- The largest OncoSec Medical Incorporated seller in Q3 2022 was Citadel Advisors, an estimated $25.3K sold.
Based on aggregated 13F filings for Q3 2022.